Fluoroquinolones Versus β-Lactam Based Regimens for the Treatment of Osteomyelitis
Authors:
- Dimitrios K. MatthaiouDMDimitrios K. Matthaiou
- Lampros I. MoraitisLMLampros I. Moraitis
- Matthew E. FalagasMFMatthew E. Falagas
- 1 May 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 33 (10) , E297-E304
Abstract
A meta-analysis of randomized control trials. To compare fluoroquinolones to β-lactams for the treatment of osteomyelitis. Treatment of osteomyelitis remains a real challenge in medicine necessitating the use of broad-spectrum antibiotics, because of the variety of the pathogens causing the infection and the fact that the infected bone may become necrotic and avascular, preventing systemic antibiotics from adequately penetrating to the infection site. A literature search was performed by 2 reviewers independently (PubMed database and the Cochrane Central Register of Controlled Trials). We identified 7 studies eligible for inclusion in our meta-analysis; ciprofloxacin, ofloxacin, and pefloxacin were used in 3, 3, and 1 study, respectively, while various β-lactams (mainly in the intravenous form) were used as comparators. There was no difference in treatment success for osteomyelitis between fluoroquinolones and β-lactams [194 patients, fixed effect model (FEM), odds ratio (OR) = 0.99, 95% confidence interval (CI) 0.51–1.91], bacteriological success (201 isolates, FEM, OR = 0.88, 95% CI = 0.45–1.70), superinfections (173 patients, FEM, OR = 1.75, 95% CI = 0.63–4.90), relapses (153 patients, FEM, OR = 1.23, 95% CI = 0.46–3.31), or adverse events (170 patients, FEM, OR = 0.47, 95% CI = 0.21–1.06). Fluoroquinolones are as effective as β-lactams for the treatment of osteomyelitis and can be considered as a useful alternative in the physician’s armamentarium. The value of fluoroquinolones for the treatment of osteomyelitis lies in the fact that they can be administered in an outpatient setting. However, they should be used with caution, so as to preserve their activity against increasingly resistant bacteria.Keywords
This publication has 15 references indexed in Scilit:
- Antibiotic Therapy for Diabetic Foot Infections: Comparison of Two Parenteral-to-Oral RegimensClinical Infectious Diseases, 1997
- Assessing the Quality of Randomized Controlled Trials:Current Issues and Future DirectionsInternational Journal of Technology Assessment in Health Care, 1996
- Ofloxacin versus parenteral therapy for chronic osteomyelitisAntimicrobial Agents and Chemotherapy, 1991
- Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitisAntimicrobial Agents and Chemotherapy, 1990
- Fluoroquinolone antimicrobial agentsClinical Microbiology Reviews, 1989
- Controlling drug effects through improved oral formulationsThe American Journal of Medicine, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Osteomyelitis: A Review of Clinical Features, Therapeutic Considerations and Unusual AspectsNew England Journal of Medicine, 1970
- Osteomyelitis: A Review of Clinical Features, Therapeutic Considerations and Unusual AspectsNew England Journal of Medicine, 1970
- Osteomyelitis: A Review of Clinical Features, Therapeutic Considerations and Unusual AspectsNew England Journal of Medicine, 1970